Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes With Novel Approaches to Targeted Therapy

Share

Program Content

Activities

  • R/R DLBCL
    Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes with Novel Approaches to Targeted Therapy
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 08, 2023

Faculty

cover img faculity

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology & Medical Oncology
Weill Cornell Medicine
New York, New York

cover img faculity

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado